Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
pamlectabart tismanitin (HDP-101)
i
Other names:
HDP-101, HDP101, HDP 101, HDP-101-ATAC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Heidelberg Pharma, Huadong Medicine
Drug class:
RNA polymerase 2 inhibitor, BCMA-targeted antibody-drug conjugate
Related drugs:
‹
MGTA-117 (4)
CD45-ADC (1)
HDP-103 (0)
belantamab mafodotin-blmf (3)
MEDI2228 (0)
BMS-986352 (0)
MGTA-117 (4)
CD45-ADC (1)
HDP-103 (0)
belantamab mafodotin-blmf (3)
MEDI2228 (0)
BMS-986352 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF17 expression
Multiple Myeloma
TNFRSF17 expression
Multiple Myeloma
HDP-101
Sensitive: D – Preclinical
HDP-101
Sensitive
:
D
HDP-101
Sensitive: D – Preclinical
HDP-101
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login